Skip to main content
SpringerLink
Log in

The Added Value of Technetium-99 m Sestamibi Scan in Patients with Primary Hyperparathyroidism and Positive Ultrasound

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Neck ultrasound (US) and Technetium-99 m Sestamibi (MIBI) scan are the most commonly used imaging studies for preoperative localization of parathyroid adenomas. The aim of this study was to determine the added value of MIBI scan and its effect on the operative plan via a hypothetical model where a stepwise approach is conducted and MIBI is considered only after the ultrasound is evaluated.

Methods

Patients who underwent parathyroidectomy for primary hyperparathyroidism (PHPT) between 2012 and 2019 at two tertiary centers were included. Data collected included demographic data, preoperative workup, operative findings and follow-up. The added value of MIBI scans was determined for patients with positive ultrasound.

Results

A total of 513 patients with positive US result and a MIBI scan were included. If a stepwise approach was conducted then MIBI scan would not change the operative plan in 492 (95.9%). Among the remaining 21 patients, MIBI scan would correctly change the ultrasound-based operative plan in only 12 (2.3%) patients, while incorrectly change the plan in 9 (1.8%), resulting in unnecessary exploration of the contralateral side. In patients with sonographic appearance of a parathyroid gland larger than 1.2 cm, MIBI scan would correctly change the operative plan in only 1 of the 287 (0.35%) patients.

Conclusions

Our study suggests that the routine use of MIBI scans may have limited added value in patients with PHPT and a positive neck ultrasound, especially in those with adenoma size larger than 1.2 cm. Positive ultrasound alone may be sufficient for the preoperative localization of parathyroid disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Press DM, Siperstein AE, Berber E et al (2013) The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 154(6):1232–1238

    Article  Google Scholar 

  2. Bilezikian JP, Bandeira L, Khan A, Cusano NE (2018) Hyperparathyroidism. Lancet 391:168–178

    Article  CAS  Google Scholar 

  3. Wilhelm SM, Wang TS, Ruan DT et al (2017) The definitive management of primary hyperparathyroidism who needs an operation? JAMA - J Am Med Assoc 317(11):959–968

    Google Scholar 

  4. Henry JF (2008) Minimally invasive thyroid and parathyroid surgery is not a question of length of the incision. Langenbeck’s Arch Surg 393(5):621–626. https://doi.org/10.1007/s00423-008-0406-3

    Article  Google Scholar 

  5. Schneider DF, Mazeh H, Chen H, Sippel RS (2014) Predictors of recurrence in primary hyperparathyroidism: an analysis of 1386 cases. Ann Surg 259(3):563–568

    Article  Google Scholar 

  6. Kuzminski SJ, Sosa JA, Hoang JK (2018) Update in parathyroid imaging. Magn Reson Imaging Clin N Am 26(1):151–166

    Article  Google Scholar 

  7. Zafereo M, Yu J, Angelos P et al (2019) American head and neck society endocrine surgery section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck 41(7):2398–2409

    Article  Google Scholar 

  8. Bilezikian JP, Khan AA, Potts JT (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94(2):335–339

    Article  CAS  Google Scholar 

  9. Bilezikian JP, Brandi ML, Eastell R et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab 99(10):3561–3569

    Article  CAS  Google Scholar 

  10. Doppman J (1986) No title. Reoperative Parathyr Surg localization Proced 18:117–132

    Google Scholar 

  11. Frank E, Watson WA, Fujimoto S, De Andrade FP, Inman J, Simental A (2020) Surgery versus imaging in non-localizing primary hyperparathyroidism: a cost-effectiveness model. Laryngoscope 130(12):E963–E969

    Article  Google Scholar 

  12. Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA (2012) A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 19(2):577–583. https://doi.org/10.1245/s10434-011-1870-5

    Article  PubMed  Google Scholar 

  13. Moghadam RN, Amlelshahbaz AP, Namiranian N et al (2017) Comparative diagnostic performance of ultrasonography and 99mTc-Sestamibi scintigraphy for parathyroid adenoma in primary hyperparathyroidism; systematic review and meta-analysis. Asian Pacific J Cancer Prev 18(12):3195–3200

    Google Scholar 

  14. Al-kurd A, Levit B, Assaly M, Mizrahi I (2018) Preoperative localization modalities in primary hyperparathyroidism: correlation with postoperative cure. Surgery 164(1):1–7

    Article  Google Scholar 

  15. Ebner Y, Garti-gross Y, Margulis A, Levy Y, Nabrisky D, Ophir D (2015) Parathyroid surgery: correlation between pre-operative localization studies and surgical outcome. Clin Endocrinol 83(5):733–738

    Article  Google Scholar 

  16. Korwar V, Yuen Chang F, Teasdale E, Suchett-Kaye I, Edwards A, Morgan J (2020) Stepwise approach for parathyroid localisation in primary hyperparathyroidism. World J Surg 44(3):803–809

    Article  Google Scholar 

Download references

Funding

The authors have no funding sources to report.

Author information

Authors and Affiliations

  1. Department of General and oncologic Surgery – Surgery C, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel

    T. Yalon & D. Assaf

  2. Rambam-Health Care Campus, Haifa, Israel

    M. Neymark, Y. Kluger & M. Mekel

  3. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

    Y. Kluger & M. Mekel

  4. Hadassah Hebrew-University Medical Center - Mount Scopus Campus, Jerusalem, Israel

    A. Rottenberg, L. Appelbaum & H. Mazeh

Authors
  1. T. Yalon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Neymark
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Rottenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Appelbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Assaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y. Kluger
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Mazeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Mekel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Yalon.

Ethics declarations

Conflict of interest

The authors declared that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yalon, T., Neymark, M., Rottenberg, A. et al. The Added Value of Technetium-99 m Sestamibi Scan in Patients with Primary Hyperparathyroidism and Positive Ultrasound. World J Surg 45, 2148–2154 (2021). https://doi.org/10.1007/s00268-021-06066-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-021-06066-8

Search

Navigation